HR+ BREAST CANCER
Clinical trials for HR+ BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HR+ BREAST CANCER trials appear
Sign up with your email to follow new studies for HR+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called NKT5097 in adults with advanced solid tumors, especially breast cancer. The drug works by breaking down two proteins that help cancer cells grow. Researchers want to find the safest dose and see if it can shrink tumors…
Matched conditions: HR+ BREAST CANCER
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New app aims to ease hormone therapy struggles for breast cancer survivors
Symptom relief Recruiting nowThis study tests a mobile health tool to help women on hormone therapy for breast cancer track and manage side effects. About 60 women who recently started hormone therapy will use the app to report symptoms and get health tips. The goal is to see if the app is easy to use and he…
Matched conditions: HR+ BREAST CANCER
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC